Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
West Virginia University
Information provided by (Responsible Party):
Mehdi Hamadani, Medical College of Wisconsin
ClinicalTrials.gov Identifier:
NCT01665677
First received: August 13, 2012
Last updated: May 5, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)